Skip to main content
. 2008 May 27;66(2):199–206. doi: 10.1111/j.1365-2125.2008.03199.x

Figure 1.

Figure 1

Mean heart rate trajectories after oral placebo (○), fingolimod (▵), and fingolimod with concurrent atropine (▪). Concurrent atropine is able to prevent the absolute nadir heart rate observed for fingolimod alone. The vertical dashed line identifies the end of the intravenous titration phase